UFP Technologies reported a strong second quarter with record results. Sales reached $100.0 million, and net income was $11.9 million, or $1.55 per diluted share. Organic sales grew by 13%, and MedTech sales increased by 16%. Gross margins improved to 29.6%.
Net income increased to $11.9 million, or $1.55 per diluted share, compared to $8.9 million, or $1.17 per diluted share, in the same quarter of 2022.
Sales grew to $100.0 million, up from $94.3 million in the second quarter of 2022.
Organic sales grew 13% after adjusting for the divestment of the Molded Fiber business.
Gross margins improved to 29.6% from 25.8% in Q2 of last year, leading to a 40% improvement in operating income.
UFP Technologies believes its strong platform and strategic acquisitions will allow it to capitalize on growing market opportunities.
Analyze how earnings announcements historically affect stock price performance